PL2576505T3 - Postać krystaliczna pleuromutyliny - Google Patents
Postać krystaliczna pleuromutylinyInfo
- Publication number
- PL2576505T3 PL2576505T3 PL11724938T PL11724938T PL2576505T3 PL 2576505 T3 PL2576505 T3 PL 2576505T3 PL 11724938 T PL11724938 T PL 11724938T PL 11724938 T PL11724938 T PL 11724938T PL 2576505 T3 PL2576505 T3 PL 2576505T3
- Authority
- PL
- Poland
- Prior art keywords
- pleuromutilin
- crystalline form
- crystalline
- Prior art date
Links
- ZRZNJUXESFHSIO-UHFFFAOYSA-N Pleuromutilin Natural products CC1C(O)C(C)(C=C)CC(OC(=O)CO)C2(C)C(C)CCC31C2C(=O)CC3 ZRZNJUXESFHSIO-UHFFFAOYSA-N 0.000 title 1
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical class C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
- C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20100450092 EP2399904A1 (en) | 2010-05-26 | 2010-05-26 | Process for the preparation of pleuromutilins |
| PCT/AT2011/000237 WO2011146954A1 (en) | 2010-05-26 | 2011-05-23 | Process for the preparation of pleuromutilins |
| EP11724938.3A EP2576505B1 (en) | 2010-05-26 | 2011-05-23 | Crystalline form of a pleuromutilin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2576505T3 true PL2576505T3 (pl) | 2018-05-30 |
Family
ID=42937801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11724938T PL2576505T3 (pl) | 2010-05-26 | 2011-05-23 | Postać krystaliczna pleuromutyliny |
| PL17197350T PL3299356T3 (pl) | 2010-05-26 | 2011-05-23 | Sposób wytwarzania pleuromutylin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17197350T PL3299356T3 (pl) | 2010-05-26 | 2011-05-23 | Sposób wytwarzania pleuromutylin |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9120727B2 (pl) |
| EP (3) | EP2399904A1 (pl) |
| JP (2) | JP6038021B2 (pl) |
| KR (1) | KR101935333B1 (pl) |
| CN (2) | CN105111117A (pl) |
| AU (1) | AU2011257938B2 (pl) |
| BR (1) | BR112012029982A2 (pl) |
| CA (1) | CA2799029C (pl) |
| DK (2) | DK2576505T3 (pl) |
| EA (1) | EA023273B1 (pl) |
| ES (2) | ES2659729T3 (pl) |
| HR (1) | HRP20220201T1 (pl) |
| HU (2) | HUE057587T2 (pl) |
| IL (1) | IL222999A (pl) |
| MA (1) | MA34332B1 (pl) |
| MX (1) | MX347176B (pl) |
| MY (1) | MY164666A (pl) |
| NZ (1) | NZ603804A (pl) |
| PH (1) | PH12012502321A1 (pl) |
| PL (2) | PL2576505T3 (pl) |
| PT (2) | PT2576505T (pl) |
| SG (1) | SG185104A1 (pl) |
| SI (1) | SI3299356T1 (pl) |
| TN (1) | TN2012000506A1 (pl) |
| TR (1) | TR201802636T4 (pl) |
| TW (1) | TWI585073B (pl) |
| UA (1) | UA108378C2 (pl) |
| WO (1) | WO2011146954A1 (pl) |
| ZA (1) | ZA201208056B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104447294A (zh) * | 2014-11-24 | 2015-03-25 | 苏州乔纳森新材料科技有限公司 | 一种3-环己烯-1-甲酸的手性拆分方法 |
| ES2843723T3 (es) * | 2015-06-17 | 2021-07-20 | Nabriva Therapeutics GmbH | Formulaciones farmacéuticas inyectables de lefamulina |
| DK3701944T3 (da) | 2015-06-18 | 2022-03-14 | Estetra Srl | Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent |
| CR20180042A (es) | 2015-06-18 | 2018-05-03 | Mithra Pharmaceuticals S A | Unidad de dosificación orodispersable que contiene un componente estetrol. |
| TWI762573B (zh) * | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
| CN107417586A (zh) * | 2017-06-21 | 2017-12-01 | 华南农业大学 | 一种截短侧耳素类抗生素及其制备方法和应用 |
| CN111989105B (zh) | 2018-04-19 | 2024-07-19 | 埃斯特拉私人有限责任公司 | 化合物以及它们在缓解绝经相关症状中的用途 |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| TWI755055B (zh) * | 2019-09-18 | 2022-02-11 | 台灣神隆股份有限公司 | 用於製備惡拉戈利鈉及其中間體的方法 |
| CN111170893B (zh) * | 2020-01-19 | 2022-04-26 | 郑州依米花手性药物研究有限公司 | Lefamulin的中间体化合物及其在Lefamulin制备中的应用 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| CN115397407A (zh) * | 2020-04-17 | 2022-11-25 | 纳布里瓦治疗有限责任公司 | 截短侧耳素类化合物的新治疗用途 |
| TW202203908A (zh) | 2020-04-17 | 2022-02-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素類之醫療用途 |
| EP4475834A1 (en) | 2022-02-09 | 2024-12-18 | Nabriva Therapeutics GMBH | Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria |
| EP4338732A1 (en) | 2022-09-16 | 2024-03-20 | Nabriva Therapeutics GMBH | Lefamulin and its derivatives for use in the treatment of tularemia |
| CN118894800A (zh) * | 2024-06-27 | 2024-11-05 | 福建省微生物研究所 | 一种Lefamulin中间体化合物的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61207370A (ja) * | 1985-03-11 | 1986-09-13 | Seitetsu Kagaku Co Ltd | 4−(メタンスルホニルオキシ)チオフエノ−ルの製法 |
| GB0017031D0 (en) * | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
| DE60317208T2 (de) * | 2002-07-24 | 2008-08-07 | Nabriva Therapeutics Forschungs Gmbh | Pleuromutilinderivate als antimikrobielle mittel |
| GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
| MXPA06000955A (es) * | 2003-08-04 | 2006-03-30 | Grindeks Jsc | Sales de meldonio, metodo para su preparacion y composiciones farmaceuticas basadas en ellas. |
| PL1658277T3 (pl) * | 2003-08-18 | 2012-10-31 | H Lundbeck As | Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek |
| EP1663220B1 (en) * | 2003-09-03 | 2009-12-02 | Glaxo Group Limited | Novel process for the preparation of pleuromutilin derivatives |
| WO2008011089A2 (en) | 2006-07-20 | 2008-01-24 | Wms Gaming Inc. | Wagering game with special-event eligibility feature based on passive game play |
| EP1908750A1 (en) * | 2006-10-05 | 2008-04-09 | Nabriva Therapeutics Forschungs GmbH | Process for the preparation of pleuromutilins |
| EP1961735B1 (en) * | 2007-02-22 | 2009-11-18 | Indena S.P.A. | Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt |
| EP1972618A1 (en) * | 2007-03-20 | 2008-09-24 | Nabriva Therapeutics AG | Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| EP2014645A1 (en) * | 2007-07-13 | 2009-01-14 | Nabriva Therapeutics AG | Pleuromutilin derivatives and their use as antimicrobials |
| EP2159220A1 (en) * | 2008-09-02 | 2010-03-03 | Nabriva Therapeutics AG | Organic compounds |
-
2010
- 2010-05-26 EP EP20100450092 patent/EP2399904A1/en not_active Withdrawn
-
2011
- 2011-05-23 TW TW100117950A patent/TWI585073B/zh not_active IP Right Cessation
- 2011-05-23 PT PT117249383T patent/PT2576505T/pt unknown
- 2011-05-23 ES ES11724938.3T patent/ES2659729T3/es active Active
- 2011-05-23 PH PH1/2012/502321A patent/PH12012502321A1/en unknown
- 2011-05-23 TR TR2018/02636T patent/TR201802636T4/tr unknown
- 2011-05-23 EP EP11724938.3A patent/EP2576505B1/en active Active
- 2011-05-23 CA CA2799029A patent/CA2799029C/en active Active
- 2011-05-23 HU HUE17197350A patent/HUE057587T2/hu unknown
- 2011-05-23 PL PL11724938T patent/PL2576505T3/pl unknown
- 2011-05-23 MA MA35484A patent/MA34332B1/fr unknown
- 2011-05-23 SI SI201132039T patent/SI3299356T1/sl unknown
- 2011-05-23 MY MYPI2012700960A patent/MY164666A/en unknown
- 2011-05-23 HR HRP20220201TT patent/HRP20220201T1/hr unknown
- 2011-05-23 WO PCT/AT2011/000237 patent/WO2011146954A1/en not_active Ceased
- 2011-05-23 KR KR1020127030731A patent/KR101935333B1/ko active Active
- 2011-05-23 UA UAA201214910A patent/UA108378C2/ru unknown
- 2011-05-23 MX MX2012013645A patent/MX347176B/es active IP Right Grant
- 2011-05-23 PT PT171973506T patent/PT3299356T/pt unknown
- 2011-05-23 DK DK11724938.3T patent/DK2576505T3/en active
- 2011-05-23 SG SG2012080339A patent/SG185104A1/en unknown
- 2011-05-23 CN CN201510488095.0A patent/CN105111117A/zh active Pending
- 2011-05-23 BR BR112012029982-4A patent/BR112012029982A2/pt not_active Application Discontinuation
- 2011-05-23 US US13/699,589 patent/US9120727B2/en active Active
- 2011-05-23 EP EP17197350.6A patent/EP3299356B1/en active Active
- 2011-05-23 HU HUE11724938A patent/HUE035861T2/hu unknown
- 2011-05-23 PL PL17197350T patent/PL3299356T3/pl unknown
- 2011-05-23 NZ NZ603804A patent/NZ603804A/en unknown
- 2011-05-23 CN CN201180036554.1A patent/CN103080083B/zh active Active
- 2011-05-23 JP JP2013511476A patent/JP6038021B2/ja active Active
- 2011-05-23 EA EA201291370A patent/EA023273B1/ru unknown
- 2011-05-23 ES ES17197350T patent/ES2909198T3/es active Active
- 2011-05-23 AU AU2011257938A patent/AU2011257938B2/en active Active
- 2011-05-23 DK DK17197350.6T patent/DK3299356T3/da active
-
2012
- 2012-10-23 TN TNP2012000506A patent/TN2012000506A1/en unknown
- 2012-10-25 ZA ZA2012/08056A patent/ZA201208056B/en unknown
- 2012-11-12 IL IL222999A patent/IL222999A/en active IP Right Grant
-
2016
- 2016-09-08 JP JP2016175859A patent/JP6501742B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2576505T3 (pl) | Postać krystaliczna pleuromutyliny | |
| SG10201500451TA (en) | Crystalline forms of a purine derivative | |
| ZA201600680B (en) | A method of motion compensation | |
| PT2723544T (pt) | Construção de uma torre | |
| ZA201301802B (en) | Besylate salt of a btk inhibitor | |
| IL256533B (en) | A method for the production of inganol-3-englate | |
| PL2589796T3 (pl) | Wytwarzanie sekcji nasadowej | |
| PT2611779T (pt) | Formas cristalinas de um inibidor do fator xa | |
| ZA201308393B (en) | Production of acetyl-coenzyme a derived compounds | |
| SG10201501226VA (en) | New crystalline form of a cyclopropyl benzamide derivative | |
| GB201004096D0 (en) | Production of polyhydroalkanoates | |
| IL230183A0 (en) | Synthesis of callistantin a and its derivatives | |
| IL223584A0 (en) | Crystalline form of a 3-phenoxymethylpyrrolidine compounds | |
| ZA201406238B (en) | Crystalline form of a succinate salt | |
| PL2407612T3 (pl) | Zastosowanie skrzynki zbrojenia | |
| IL230977A (en) | A crystalline form of relapaldib | |
| TWM390210U (en) | Improved structure of a tool holder | |
| GB2497112B (en) | Manufacture of a package | |
| TWM390844U (en) | Structure improvement of a screwdriver | |
| TWM402373U (en) | Improved structure of a faucet | |
| TWM402641U (en) | Structure of a place box | |
| TWM385440U (en) | Structure improvement of a screwdriver | |
| HK1178531A (zh) | 环丙基苯甲酰胺衍生物的新结晶形式 | |
| IL231452A0 (en) | Amorphous form of dolutegravir | |
| GB201115520D0 (en) | New design of a toothbrush |